Do you think your research can provide a solution to a medical problem? Are you interested in translating your technology into patient benefit but have questions on patent filing, out-licensing, or company creation?
Application deadline: 23:59 on 21 February 2022
Experts from Cambridge Enterprise, Cancer Research UK, the Milner Therapeutics Institute and Apollo Therapeutics are here to help you understand the potential of your idea/technology and provide insights on how to develop it. The panel has substantial experience in academic–industry collaborations, Intellectual Property protection, product development and company creation and can advise on the support available from their respective companies and organisations, including training, funding and expanding your network.
Eligibility
This opportunity is offered to researchers (senior, junior, associates, postdocs, clinical and non-clinical) and PhD students of the University of Cambridge. Your research should have the potential to address current medical challenges and be applicable to models/methods, diagnostics, therapeutics, biomarkers, targets or devices, at any development stage.
Programme schedule
You will have 5 minutes to present your idea/technology and you will receive 15 minutes of dedicated time from the experts to address your 2 questions and provide any additional feedback.
Selection criteria
Accuracy and appropriateness of the information provided and translation potential of your research to deliver patient benefit will be the main selection criteria. The out-come will be emailed to you on 1st March, along with your time slot for presentation if you are selected.
Location
Milner Therapeutics Institute – Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus. Please note the meeting will be moved online if necessary.
Project proposal guidance
Click here to download the template for your 5 minute presentation. Information shared during the meeting will be kept confidential.
Forward your completed template to CPPA@cancer.org.uk using the subject heading ‘Innovation Clinic.’ If you have any questions please email Jasmeet.Virdee@cancer.org.uk
The experts
The experts listed below have agreed to support this event by answering questions and providing feedback on the selected technologies/ideas in their field of expertise. Some of the experts will be present in person at the clinic with others joining online where appropriate.
Cancer Research UK
- Jonathan Brown, Business Development Executive – Commercial Partnerships
- Neil Jones, Associate Director, Target Validation & Disease Positioning
- Matthew Farren, Regional Translational Executive
- Lucia Coral, Technology Translation Manager
- Julie Little, Associate Director Strategic Alliances, Commercial Partnerships
- Tanya Moore, Business Development Executive
- Alessia Errico, Regional Translation Lead-London and Entrepreneurial Programmes Lead
Apollo Therapeutics
- Richard Butt, Chief Scientific Officer
Cambridge Enterprise
- Rachel Atfield, Commercialisation Manager – Life Sciences
- Amanda Wooding, Investment Director – Life Sciences
Milner Therapeutics Institute
- Nicola McCarthy, MTI Consortium Manager
- Kathryn Chapman, Deputy Director
